242 related articles for article (PubMed ID: 18438813)
1. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome.
Gattorno M; Pelagatti MA; Meini A; Obici L; Barcellona R; Federici S; Buoncompagni A; Plebani A; Merlini G; Martini A
Arthritis Rheum; 2008 May; 58(5):1516-20. PubMed ID: 18438813
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene.
Pelagatti MA; Meini A; Caorsi R; Cattalini M; Federici S; Zulian F; Calcagno G; Tommasini A; Bossi G; Sormani MP; Caroli F; Plebani A; Ceccherini I; Martini A; Gattorno M
Arthritis Rheum; 2011 Apr; 63(4):1141-50. PubMed ID: 21225694
[TBL] [Abstract][Full Text] [Related]
3. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
Ozen S; Bilginer Y; Aktay Ayaz N; Calguneri M
J Rheumatol; 2011 Mar; 38(3):516-8. PubMed ID: 21159830
[TBL] [Abstract][Full Text] [Related]
4. Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis.
Obici L; Meini A; Cattalini M; Chicca S; Galliani M; Donadei S; Plebani A; Merlini G
Ann Rheum Dis; 2011 Aug; 70(8):1511-2. PubMed ID: 21173015
[No Abstract] [Full Text] [Related]
5. Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
Rigante D; Ansuini V; Bertoni B; Pugliese AL; Avallone L; Federico G; Stabile A
Rheumatol Int; 2006 Nov; 27(1):97-100. PubMed ID: 16871408
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
Calligaris L; Marchetti F; Tommasini A; Ventura A
Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
[TBL] [Abstract][Full Text] [Related]
7. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant.
Camprubí D; Mitjavila F; Arostegui JI; Corbella X
Int J Rheum Dis; 2017 Apr; 20(4):510-514. PubMed ID: 27990755
[TBL] [Abstract][Full Text] [Related]
9. Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience.
Ugurlu S; Ergezen B; Egeli BH; Selvi O; Ozdogan H
Rheumatology (Oxford); 2021 May; 60(5):2327-2332. PubMed ID: 33295622
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.
Gentileschi S; Rigante D; Vitale A; Sota J; Frediani B; Galeazzi M; Cantarini L
Clin Rheumatol; 2017 Jul; 36(7):1687-1690. PubMed ID: 28536823
[TBL] [Abstract][Full Text] [Related]
11. Anakinra for colchicine refractory familial Mediterranean fever: a cohort of 44 patients.
Marko L; Shemer A; Lidar M; Grossman C; Druyan A; Livneh A; Kivity S
Rheumatology (Oxford); 2021 Jun; 60(6):2878-2883. PubMed ID: 34144604
[TBL] [Abstract][Full Text] [Related]
12. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
[TBL] [Abstract][Full Text] [Related]
13. Anakinra treatment in drug-resistant Behcet's disease: a case series.
Cantarini L; Vitale A; Scalini P; Dinarello CA; Rigante D; Franceschini R; Simonini G; Borsari G; Caso F; Lucherini OM; Frediani B; Bertoldi I; Punzi L; Galeazzi M; Cimaz R
Clin Rheumatol; 2015 Jul; 34(7):1293-301. PubMed ID: 24305945
[TBL] [Abstract][Full Text] [Related]
14. Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra.
Cattalini M; Meini A; Monari P; Gualdi G; Arisi M; Pelucchi F; Bolognini S; Gattorno M; Calzavara-Pinton PG; Plebani A
Dermatol Online J; 2013 Nov; 19(11):20405. PubMed ID: 24314780
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
[TBL] [Abstract][Full Text] [Related]
16. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
[TBL] [Abstract][Full Text] [Related]
17. Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient.
Mitroulis I; Papadopoulos VP; Konstantinidis T; Ritis K
Neth J Med; 2008 Dec; 66(11):489-91. PubMed ID: 19075317
[TBL] [Abstract][Full Text] [Related]
18. Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.
Shendi HM; Walsh D; Edgar JD
Rheumatol Int; 2012 Jan; 32(1):249-51. PubMed ID: 20020131
[TBL] [Abstract][Full Text] [Related]
19. Familial mediterranean fever treated with anakinra: A case report.
Espíldora-Hernández J; Abarca-Costalago M
Reumatol Clin; 2017; 13(2):120-121. PubMed ID: 27377451
[No Abstract] [Full Text] [Related]
20. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
Ben-Zvi I; Kukuy O; Giat E; Pras E; Feld O; Kivity S; Perski O; Bornstein G; Grossman C; Harari G; Lidar M; Livneh A
Arthritis Rheumatol; 2017 Apr; 69(4):854-862. PubMed ID: 27860460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
